Roche cobas Influenza Test Recall Due to False Negative Results
Roche Molecular Systems is recalling its cobas Influenza A/B & SARS-CoV-2 test because it has reported false negative results for Influenza A, which may delay diagnosis and treatment.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II device recall with confirmed false negative test results affecting a critical diagnostic function. While no hospitalizations or illnesses have been reported, the false negatives represent a documented risk-of-harm to patients who may receive inaccurate test results, leading to delayed diagnosis and treatment.
Plain-English summary
Roche Molecular Systems, Inc. is recalling the cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on cobas 5800/6800/8800 Systems (Material Number 09446125190). This device is identified by UDI-DI 00875197006827, with all in-date lots included in the recall. The recall affects 9,948 units, primarily distributed outside the United States, though the device has been distributed domestically nationwide and worldwide.
Roche received customer complaints regarding false negative results for Influenza A and late Influenza A Target Ct values. A false negative influenza A result may lead to additional testing, psychological distress, and delays to targeted therapy for influenza as well as delays to obtaining a true diagnosis. These issues may impact the accuracy of patient testing and clinical decision-making.
The recalled product
- Product
- cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas 5800/6800/8800 Systems; Material Number 09446125190
- Manufacturer
- Roche Molecular Systems, Inc.
- Category
- Medical Device — Diagnostic Test
- Affected units
- 9,948
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UDI-DI 00875197006827 All in-date lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Roche Molecular Systems, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Roche Molecular Systems, Inc.
See all →- HighRoche Influenza A/B and RSV Test Kit Recalled for False Negative Results
FDA (Devices) · 2023-02-15
- HighRoche cobas Flu/COVID assay recalled for false negative influenza results
FDA (Devices) · 2023-02-15
- HighMedical Device Recall: Roche cobas 5800 False Results Due to Baseline Anomalies
FDA (Devices) · 2022-10-26
- ModerateCobas Liat respiratory virus analyzer units recalled for false Influenza B results
FDA (Devices) · 2022-04-06
- HighCobas EGFR Mutation Test v2 may return false mutation detection results
FDA (Devices) · 2021-10-20
Same hazard · false negative results
See all →- HighBioFire Spotfire Respiratory/Sore Throat Panel Recall for False Negatives
FDA (Devices) · 2026-05-13
- HighBD COR system software issue could produce possible false negative results
FDA (Devices) · 2025-07-30
- HighBioFire Respiratory Panel 2.1 plus Kit recalled for manufacturing defect
FDA (Devices) · 2025-06-04
- HighFilmArra Pneumonia Panel Plus Diagnostic Kit Recalled for Control and Test Failures
FDA (Devices) · 2025-04-16
- HighCandida ID Antigen recalled for reduced sensitivity, potential false negatives
FDA (Devices) · 2025-03-26